Tags

Type your tag names separated by a space and hit enter

Topical psoriasis therapy.
Am Fam Physician. 1999 Feb 15; 59(4):957-62, 964.AF

Abstract

Psoriasis is a common dermatosis, affecting from 1 to 3 percent of the population. Until recently, the mainstays of topical therapy have been corticosteroids, tars, anthralins and keratolytics. Recently, however, vitamin D analogs, a new anthralin preparation and topical retinoids have expanded physicians' therapeutic armamentarium. These new topical therapies offer increased hope and convenience to the large patient population with psoriasis.

Links

FREE Publisher Full Text

Authors+Show Affiliations

Federman DG
Yale University School of Medicine, New Haven, Connecticut, USA.
Froelich CW
No affiliation info available
Kirsner RS
No affiliation info available

MeSH

Administration, CutaneousAdministration, TopicalAnthralinAnti-Inflammatory AgentsCalcitriolCoal TarDermatologic AgentsHumansKeratolytic AgentsNicotinic AcidsPatient Education as TopicPsoriasisRetinoidsTeaching MaterialsVitamin D

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

10068717

Citation

Federman, D G., et al. "Topical Psoriasis Therapy." American Family Physician, vol. 59, no. 4, 1999, pp. 957-62, 964.
Federman DG, Froelich CW, Kirsner RS. Topical psoriasis therapy. Am Fam Physician. 1999;59(4):957-62, 964.
Federman, D. G., Froelich, C. W., & Kirsner, R. S. (1999). Topical psoriasis therapy. American Family Physician, 59(4), 957-62, 964.
Federman DG, Froelich CW, Kirsner RS. Topical Psoriasis Therapy. Am Fam Physician. 1999 Feb 15;59(4):957-62, 964. PubMed PMID: 10068717.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Topical psoriasis therapy. AU - Federman,D G, AU - Froelich,C W, AU - Kirsner,R S, PY - 1999/3/9/pubmed PY - 2001/5/11/medline PY - 1999/3/9/entrez SP - 957-62, 964 JF - American family physician JO - Am Fam Physician VL - 59 IS - 4 N2 - Psoriasis is a common dermatosis, affecting from 1 to 3 percent of the population. Until recently, the mainstays of topical therapy have been corticosteroids, tars, anthralins and keratolytics. Recently, however, vitamin D analogs, a new anthralin preparation and topical retinoids have expanded physicians' therapeutic armamentarium. These new topical therapies offer increased hope and convenience to the large patient population with psoriasis. SN - 0002-838X UR - https://www.unboundmedicine.com/medline/citation/10068717/Topical_psoriasis_therapy_ L2 - https://www.aafp.org/link_out?pmid=10068717 DB - PRIME DP - Unbound Medicine ER -